Genprex Inc — Quarterly Financial Statistics (NASDAQ:GNPX)

Financials

Cash from operating activities -1.41 M-3.1 M-4.16 M-3.86 M-3.19 M -14.31 M Cash from investing activities -773.48 K-773.48 K000 -773.48 K Cash from financing activities 1.22 M3.98 M6.03 M1.74 M2.94 M 14.7 M Free cash flow -1.41 M-3.1 M-4.16 M-3.86 M-3.19 M -14.31 M

新闻

Genprex股价因日本和欧洲专利获批而飙升

Genprex stock jumps on Japan, Europe patent approvals

Genprex获得日本和欧洲癌症疗法专利

Genprex receives Japanese and European patents for cancer therapy

Genprex在澳大利亚获得癌症疗法专利批准

Genprex receives patent approval in Australia for cancer therapy

Genprex reports positive data for diabetes gene therapy in animal studies

Genprex公司报告可能符合纳斯达克股票上市规则

Genprex reports potential compliance with Nasdaq equity listing rule

Genprex重获纳斯达克最低竞价合规资格，获得股权延期

Genprex公布肺癌基因疗法的一期临床数据

Genprex reports phase 1 data for lung cancer gene therapy